Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient

Sponsor
Maria Bano (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03263312
Collaborator
(none)
50
1
1
89
0.6

Study Details

Study Description

Brief Summary

This is a single center prospective longitudinal exercise training study and will enroll approximately 50 Fontan patients and 20 controls of a similar age, gender, BMI and physical activity level between the ages of 10-40 years.

Participants will undergo an MRI of the Fontan circulation. This will include imaging of the heart, lung and liver. This will include specific imaging for tissue characterization and assessment of myocardial fibrosis, liver fibrosis and disproportionate pulmonary blood flow. The investigators will then draw blood (approximately 10 ml) for assessment of serum biomarkers and circulating microRNAs of interest. The participants will undergo exercise testing and will then start a 3-6 month long cardiac rehabilitation program. After the 3-6 month study period the participants will return back for a follow up and repeat all the testing completed at enrollement.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise
N/A

Detailed Description

This is a single center prospective longitudinal study and will enroll approximately 50 Fontan patients and 20 controls of a similar age, gender, BMI and physical activity level between the ages of 10-40 years. The investigators will enroll from pediatric cardiology and heart failure clinics and inpatient care units at Children's Health Dallas, adult congenital heart disease clinics and inpatient care units at Clements University Hospital and the Clinical Heart Center. This study will evaluate the multimodality biomarkers for assessment of Fontan circulation including heart, liver and lung and change in these markers with exercise training.

Participants will receive an MRI of the Fontan circulation. This will include imaging of the heart, lung and liver. A blood draw (approximately 10 ml) for assessment of serum biomarkers and circulating microRNAs of interest will be completed. The participants will also complete exercise testing and will then start a 3-6 month long cardiac rehabilitation program. Frequent phone follow up (conducted by the research staff) and regular download of data from heart rate monitors will ensure adherence.

After the 3-6 month study period the participants will return for a follow up and repeat all testing completed at enrollment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient
Actual Study Start Date :
Jan 1, 2018
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fontan Patients

All Fontan patients included in this study will be part of an exercise intervention 2-6 times/week for 3-6 months.

Behavioral: Exercise
Exercise training all patients enrolled.
Other Names:
  • Training
  • Outcome Measures

    Primary Outcome Measures

    1. Peak VO2 [6 months]

      Improvement in Peak VO2 with 6 months of exercise training

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Presence of a congenital heart defect that leads to single ventricle physiology

    • Previously performed TCPA surgery

    • Current age 10 years to 40 years

    • Informed consent

    Exclusion Criteria:
    • History of exercise intolerance (peak VO2<12ml/kg/min)

    • Unstable arrhythmia at the time of screening

    • Listed or being evaluated for heart transplantation

    • Pregnancy or breast feeding

    • Patient with pacemaker, AV block other than 1st degree block, sick sinus syndrome or other arrhythmia that may influence ability to perform exercise test or magnetic resonance imaging

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children'sMCD Irving Texas United States 75063

    Sponsors and Collaborators

    • Maria Bano

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Maria Bano, Assistant Professor, Children's Medical Center Dallas
    ClinicalTrials.gov Identifier:
    NCT03263312
    Other Study ID Numbers:
    • STU 122016-037
    First Posted:
    Aug 28, 2017
    Last Update Posted:
    Sep 5, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Maria Bano, Assistant Professor, Children's Medical Center Dallas
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 5, 2021